Recent Finacing
Recent Raise
Dilon Technologies develops and markets surgical and diagnostic devices—HEMOBLAST Bellows for control of minimal-to-moderate bleeding, MarginProbe for intraoperative breast margin assessment, and Navigator Gamma Probe for radio-guided tumor localization.
